Press & news - FluoGuide A/S

16 September, 2025 FluoGuide receives positive FDA feedback on FG001 in high-grade glioma News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-listing English Regulatory Listing Regulation IR

Copenhagen, Denmark, 16 September 2025 – FluoGuide A/S ("FluoGuide" or the "Company") received positive feedback...

28 August, 2025 FluoGuide A/S publishes Interim Report H1 2025 News English Regulatory Listing Regulation Report Interim Q2 IR

Copenhagen, Denmark, 28 August 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...

22 August, 2025 Invitation to FluoGuide A/S (Nasdaq: FLUO) webcast on 28 August 2025 News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

FluoGuide A/S will publish its Interim Report Q2 2025 on Thursday 28 August 2025. The following event will take place later that day...

10 August, 2025 FluoGuide Q&A sessions highlight partnerships accelerating FG001 commercialization News English PR

Copenhagen, Denmark, 10 August 2025 – FluoGuide A/S is releasing a summary of its live-recorded interview at Redeye (English)...

31 July, 2025 Invitation: FluoGuide presentations on strategic collaborations and FG001 commercialization News English PR

FluoGuide is advancing its position in head and neck cancer treatment. On 21 July 2025, the company announced a strategic collaboration...

21 July, 2025 FluoGuide enters collaboration with global MedTech company Olympus News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English Regulatory MAR IR

Copenhagen, Denmark, 21 July 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing...

3 July, 2025 Update on 2025 Outlook and Company progress News Corporate Action Other mfn-ext-nq mfn-ext-nq-corporate-action English IR

Copenhagen, Denmark, 3 July 2025 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech...

10 June, 2025 FG001 clinical data in High-Grade Glioma is now published in Neurosurgery News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

Copenhagen, Denmark – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused...

28 May, 2025 FluoGuide A/S publishes interim report for the period January – March 2025 - On track - first patients enrolled in CT-005 News English Regulatory Listing Regulation Report Interim Q1 IR

Copenhagen, Denmark, 28 May 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results...

2025

FluoGuideCalendar & events